Table 2.
At Presentation | p * | All Patients | p † | |||
---|---|---|---|---|---|---|
MRMP (n = 41) | MSMP (n = 15) | Initial (n = 56) | Follow-Up (n = 33) | |||
Hb | 12.3 (11.5–12.9) | 12.4 (11.8–13.3) | 0.774 | 12.4 (11.7–13.0) | 12.5 (12.0–13.2) | 0.068 |
WBC | 7.3 (5.7–8.8) | 7.6 (6.1–8.7) | 0.76 | 7.5 (5.7–8.7) | 9.8 (7.9–14.1) | <0.001 |
N (%) | 65.9 (53.4–70.3) | 62.0 (48.0–67.8) | 0.379 | 64.8 (52.6–70.2) | 74.6 (58.5–79.3) | 0.026 |
L (%) | 24.0 (19.1–37.0) | 25.2 (20.5–38.3) | 0.494 | 24.8 (20.0–37.3) | 18.2 (11.3–30.3) | 0.033 |
M (%) | 8.1 (6.4–9.1) | 8.4 (6.9–9.2) | 0.465 | 8.1 (6.8–9.1) | 7.7 (5.0–10.9) | 0.823 |
AST | 27 (23–33) | 26 (21–30) | 0.262 | 27 (23–32) | 24 (20–29) | <0.001 |
ALT | 12 (10–16) | 12 (8–14) | 0.546 | 12 (10–15) | 19 (13–26) | <0.001 |
ALP | 169 (153–207) | 167 (141–180) | 0.259 | 168 (150–202) | 163 (126–186) | 0.022 |
LDH | 271 (247–330) | 250 (220–273) | 0.085 | 269 (243–317) | 270 (231–308) | 0.007 |
ESR | 14 (8–24) | 17 (9–29) | 0.691 | 14 (9–24) | 11 (4–17) | 0.004 |
CRP | 1.7 (1.0–2.6) | 2.2 (0.8–3.8) | 0.505 | 1.8 (0.9–2.8) | 0.4 (0.1–0.9) | <0.001 |
Values are presented as median (IQR). Hb: hemoglobin (g/dL), WBC: white blood cell count (×103/mm3), N: neutrophil, L: lymphocyte, M: monocyte, AST: aspartate aminotransferase (U/L), ALT: alanine aminotransferase (U/L), ALP: alkaline phosphatase (U/L), LDH: lactate dehydrogenase (U/L), ESR: erythrocyte sedimentation rate (mm/h), CRP: C-reactive protein (mg/dL), MRMP: macrolide-resistant Mycoplasma pneumoniae, MSMP: macrolide-sensitive Mycoplasma pneumoniae, p: p-value. * Statistical analysis was performed between MRMP and MSMP groups. p-values were obtained using nonparametric t-test (Mann–Whitney test) for continuous variables. † Laboratory findings at admission and before discharge were compared. p-values were obtained using nonparametric paired t-test (Wilcoxon) for continuous variables.